• Sudarshan Pharma allotted USD 10 million 8% foreign currency convertible bonds due 2029.
• Bonds are convertible into equity shares at a price of Rs. 30.19 per share.
• Company retains option to issue additional USD 10 million FCCBs within 60 days.
• Allotment approved by board on May 21, 2026, following shareholder and regulatory approvals.